Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
304.60    8.30 (2.80%)
Bid:
303.70
Ask:
303.90
Spread: 0.20 (0.066%)
Market Cap: £6.75b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

Directorate Changes

12 Mar 2021 09:00

RNS Number : 9998R
Sainsbury(J) PLC
12 March 2021
 

12 March 2021

J Sainsbury plc - Directorate Changes

Appointment of Adrian Hennah as Non-Executive Director and Chair of Audit Committee

J Sainsbury plc today announces that Adrian Hennah will join the Board as a Non-Executive Director. Adrian will join the Audit Committee and Nomination Committee on 1 April 2021 and will take over as Chair of the Audit Committee following the AGM.

Adrian will replace David Keens, who is not seeking re-election to the Board at the July 2021 AGM after six years of service.

Commenting on the appointment, Martin Scicluna, Chairman of Sainsbury's, said:

"I am delighted to welcome Adrian as a Non-Executive Director and Chair of the Audit Committee. As a highly accomplished CFO of three FTSE100 companies spanning 18 years, he has significant and varied expertise. Additionally, Adrian was a Non-Executive Director and Audit Committee Chair of another FTSE100 company for nine years and I am confident he will bring fresh thinking to our Board as we deliver against our plan.

"I would like to thank David Keens for his six years of service. He has been a thoughtful and influential voice on the Board and we are grateful for his significant contribution."

Adrian Hennah said:

"I am very pleased to be joining Sainsbury's and look forward to bringing my experience to the Board. I am familiar with the business through previous roles and have always been impressed by the company's values and commitment to do the right thing for its customers. It is an exciting time to be involved in food retail and I am looking forward to getting started."

Adrian spent 18 years in Chief Financial Officer (CFO) roles at three FTSE 100 companies. He was CFO at RB for seven years and held the same position at Smith & Nephew and Invensys. Prior to this he spent 18 years at GSK working in both finance and operations. Adrian began his career at PWC.

Adrian was previously Non-Executive Director and Chair of the Audit Committee at RELX. He stepped down from the Board last year having completed nine years of service. No further information is required to be disclosed under 9.6.13R of the UK Listing Rules.

 

Ends

Enquiries:

Investor Relations Media Relations

James Collins +44 (0) 20 7695 0080 Rebecca Reilly +44 (0) 20 7695 7295

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZFLFFFXLEBBF
Date   Source Headline
1st Jun 20218:50 amRNSDirector Declaration
14th May 20213:05 pmRNSDirector/PDMR Shareholding
10th May 20215:15 pmRNSDirector/PDMR Shareholding
10th May 202112:00 pmRNSDirector/PDMR Shareholding
5th May 20212:30 pmRNSHolding(s) in Company
4th May 20212:15 pmRNSTotal Voting Rights
29th Apr 20213:30 pmRNSHolding(s) in Company
28th Apr 20217:00 amRNSFinal Results
16th Apr 20212:30 pmRNSDirector/PDMR Shareholding
13th Apr 20213:00 pmRNSHolding(s) in Company
13th Apr 20213:00 pmRNSHolding(s) in Company
13th Apr 20217:05 amRNSDirector Declaration
1st Apr 20213:10 pmRNSTotal Voting Rights
1st Apr 20211:45 pmRNSHolding(s) in Company
19th Mar 20213:30 pmRNSDirector/PDMR Shareholding
12th Mar 20219:00 amRNSDirectorate Changes
3rd Mar 20213:15 pmRNSSainsbury’s to forgo business rates relief
1st Mar 20212:30 pmRNSTotal Voting Rights
26th Feb 202112:30 pmRNSHolding(s) in Company
24th Feb 20214:55 pmRNSHolding(s) in Company
22nd Feb 20214:45 pmRNSHolding(s) in Company
19th Feb 20211:15 pmRNSDirector/PDMR Shareholding
5th Feb 20219:00 amRNSDirector Declaration
1st Feb 20214:10 pmRNSBlock listing Interim Review
1st Feb 20212:40 pmRNSTotal Voting Rights
29th Jan 20213:00 pmRNSHolding(s) in Company
25th Jan 202112:30 pmRNSDirector/PDMR Shareholding
19th Jan 202111:00 amRNSDirectorate Change
12th Jan 20211:00 pmRNSDirector/PDMR Shareholding
7th Jan 20217:00 amRNSQ3 Trading Statement
4th Jan 202112:20 pmRNSTotal Voting Rights
29th Dec 20202:00 pmRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSDirectorate Change – Sainsbury’s Bank
15th Dec 202010:05 amRNSDirector/PDMR Shareholding
3rd Dec 20207:00 amRNSSainsbury’s to forgo business rates relief
1st Dec 20202:47 pmRNSTotal Voting Rights
27th Nov 20201:30 pmRNSDirector/PDMR Shareholding
17th Nov 202012:00 pmRNSResponse to press speculation
12th Nov 20202:51 pmRNSAdjustment of Conversion Price
5th Nov 20207:00 amRNSHalf-year Report
2nd Nov 20202:20 pmRNSTotal Voting Rights
30th Oct 20202:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20203:30 pmRNSDirector/PDMR Shareholding
1st Oct 20201:30 pmRNSTotal Voting Rights
17th Sep 20201:30 pmRNSHolding(s) in Company
4th Sep 20201:05 pmRNSDirector/PDMR Shareholding
2nd Sep 202012:30 pmRNSHolding(s) in Company
1st Sep 20202:00 pmRNSTotal Voting Rights
25th Aug 20209:30 amRNSAdditional Listing
7th Aug 20202:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.